GASTALDELLI, AMALIA
GASTALDELLI, AMALIA
Istituto di Fisiologia Clinica - IFC
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: Rationale and design of a prospective multicentre study
2025 De Jong, V. D.; Alings, M.; Bruha, R.; Cortez-Pinto, H.; Dedoussis, G. V.; Doukas, M.; Francque, S.; Fournier-Poizat, C.; Gastaldelli, A.; Hankemeier, T.; Holleboom, A. G.; Miele, L.; Moreno, C.; Muris, J. W. M.; Ratziu, V.; Romero-Gomez, M.; Schattenberg, J. M.; Serfaty, L.; Stefan, D. C.; Tushuizen, M. E.; Verheij, J.; Willemse, J.; Franco, O. H.; Grobbee, D. E.; Castro Cabezas, M.
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents
2025 Gastaldelli, A.
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features
2024 Lori, G.; Pastore, M.; Navari, N.; Piombanti, B.; Booijink, R.; Rovida, E.; Tusa, I.; Lewinska, M.; Andersen, J. B.; Lottini, T.; Arcangeli, A.; Taddei, M. L.; Pranzini, E.; Mancini, C.; Anceschi, C.; Madiai, S.; Sacco, E.; Rota, S.; Trapani, A.; Agrimi, G.; Ramazzotti, M.; Ostano, P.; Peraldo Neia, C.; Parri, M.; Carli, F.; Sabatini, S.; Gastaldelli, A.; Marra, F.; Raggi, C.
Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies
2024 Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A.
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery
2024 Honka, H.; Gastaldelli, A.; Pezzica, S.; Peterson, R.; Defronzo, R.; Salehi, M.
Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity
2024 Angelini, Giulia; Russo, Sara; Carli, Fabrizia; Infelise, Patrizia; Panunzi, Simona; Bertuzzi, Alessandro; Caristo, Maria Emiliana; Lembo, Erminia; Calce, Roberta; Bornstein, Stefan R.; Gastaldelli, Amalia; Mingrone, Geltrude
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2024 Tacke, F.; Horn, P.; Wong, V. W. -S.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D.
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Tacke, F.; Horn, P.; Wai-Sun Wong, V.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D.
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
2024 Dicker, D.; Fruhbeck, G.; Vettor, R.; Gastaldelli, A.; Yki-Jarvinen, H.; Schick, F.; Roden, M.; Valenti, L.; Zelber-Sagi, S.; Francque, S.; Bugianesi, E.; Ratziu, V.; Wong, V. W. -S.; Horn, P.; Tack, F.
Effects of Mixtures of Emerging Pollutants and Drugs on Modulation of Biomarkers Related to Toxicity, Oxidative Stress, and Cancer
2024 Manuguerra, Simona; Carli, Fabrizia; Scoditti, Egeria; Santulli, Andrea; Gastaldelli, Amalia; Messina, Concetta Maria
ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model
2024 Angelini, Giulia; Galvao Neto, Manoel; Boskoski, Ivo; Caristo, Maria Emiliana; Russo, Sara; Proto, Luca; Previti, Elena; Olsson, Lisa; Aggarwal, Hobby; Pezzica, Samantha; Ferrari, Elisa; Bove, Vincenzo; Genco, Alfredo; Bornstein, Stefan; Tremaroli, Valentina; Gastaldelli, Amalia; Mingrone, Geltrude
GLP-1 enhances β-cell response to protein ingestion and bariatric surgery amplifies it
2024 Rayas, M.; Pezzica, S.; Honka, H.; Carli, F.; Peterson, R.; Defronzo, R.; Gastaldelli, A.; Salehi, M.
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss
2024 Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A.
Hepatic glucose metabolism in the steatotic liver
2024 Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A.
Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study
2024 Patarrao, R. S.; Meneses, M. J.; Ghadieh, H. E.; Herrera, L.; Duarte, S.; Ribeiro, R. T.; Raposo, J. F.; Schmitt, V.; Singer, B. B.; Gastaldelli, A.; Penha-Goncalves, C.; Najjar, S. M.; Macedo, M. P.
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
2024 Carli, F.; Della Pepa, G.; Sabatini, S.; Vidal Puig, A.; Gastaldelli, A.
Brain histone beta-hydroxybutyrylation couples metabolism with gene expression
2023 Cornuti, Sara; Chen, Siwei; Lupori, Leonardo; Finamore, Francesco; Carli, Fabrizia; Samad, Muntaha; Fenizia, Simona; Caldarelli, Matteo; Damiani, Francesca; Raimondi, Francesco; Mazziotti, Raffaele; Magnan, Christophe; Rocchiccioli, Silvia; Gastaldelli, Amalia; Baldi, Pierre; Tognini, Paola
Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy
2023 Drago, Gaspare; Ruggieri, Silvia; Sprovieri, Mario; Rizzo, Giulia; Colombo, Paolo; Giosuè, Cristina; Quinci, Enza; Traina, Anna; Gastaldelli, Amalia; Cibella, Fabio; Panunzi, Simona
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
2023 Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
2023 Eskridge, W.; Cryer, D. R.; Schattenberg, J. M.; Gastaldelli, A.; Malhi, H.; Allen, A. M.; Noureddin, M.; Sanyal, A. J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Global research initiative for patient screening on MASH (GRIPonMASH) protocol: Rationale and design of a prospective multicentre study | 1-gen-2025 | De Jong, V. D.; Alings, M.; Bruha, R.; Cortez-Pinto, H.; Dedoussis, G. V.; Doukas, M.; Francque, S.; Fournier-Poizat, C.; Gastaldelli, A.; Hankemeier, T.; Holleboom, A. G.; Miele, L.; Moreno, C.; Muris, J. W. M.; Ratziu, V.; Romero-Gomez, M.; Schattenberg, J. M.; Serfaty, L.; Stefan, D. C.; Tushuizen, M. E.; Verheij, J.; Willemse, J.; Franco, O. H.; Grobbee, D. E.; Castro Cabezas, M. | |
| Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents | 1-gen-2025 | Gastaldelli, A. | |
| Altered fatty acid metabolism rewires cholangiocarcinoma stemness features | 1-gen-2024 | Lori, G.; Pastore, M.; Navari, N.; Piombanti, B.; Booijink, R.; Rovida, E.; Tusa, I.; Lewinska, M.; Andersen, J. B.; Lottini, T.; Arcangeli, A.; Taddei, M. L.; Pranzini, E.; Mancini, C.; Anceschi, C.; Madiai, S.; Sacco, E.; Rota, S.; Trapani, A.; Agrimi, G.; Ramazzotti, M.; Ostano, P.; Peraldo Neia, C.; Parri, M.; Carli, F.; Sabatini, S.; Gastaldelli, A.; Marra, F.; Raggi, C. | |
| Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies | 1-gen-2024 | Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A. | |
| Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery | 1-gen-2024 | Honka, H.; Gastaldelli, A.; Pezzica, S.; Peterson, R.; Defronzo, R.; Salehi, M. | |
| Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity | 1-gen-2024 | Angelini, Giulia; Russo, Sara; Carli, Fabrizia; Infelise, Patrizia; Panunzi, Simona; Bertuzzi, Alessandro; Caristo, Maria Emiliana; Lembo, Erminia; Calce, Roberta; Bornstein, Stefan R.; Gastaldelli, Amalia; Mingrone, Geltrude | |
| EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 1-gen-2024 | Tacke, F.; Horn, P.; Wong, V. W. -S.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D. | |
| EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) | 1-gen-2024 | Tacke, F.; Horn, P.; Wai-Sun Wong, V.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D. | |
| EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary | 1-gen-2024 | Dicker, D.; Fruhbeck, G.; Vettor, R.; Gastaldelli, A.; Yki-Jarvinen, H.; Schick, F.; Roden, M.; Valenti, L.; Zelber-Sagi, S.; Francque, S.; Bugianesi, E.; Ratziu, V.; Wong, V. W. -S.; Horn, P.; Tack, F. | |
| Effects of Mixtures of Emerging Pollutants and Drugs on Modulation of Biomarkers Related to Toxicity, Oxidative Stress, and Cancer | 1-gen-2024 | Manuguerra, Simona; Carli, Fabrizia; Scoditti, Egeria; Santulli, Andrea; Gastaldelli, Amalia; Messina, Concetta Maria | |
| ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model | 1-gen-2024 | Angelini, Giulia; Galvao Neto, Manoel; Boskoski, Ivo; Caristo, Maria Emiliana; Russo, Sara; Proto, Luca; Previti, Elena; Olsson, Lisa; Aggarwal, Hobby; Pezzica, Samantha; Ferrari, Elisa; Bove, Vincenzo; Genco, Alfredo; Bornstein, Stefan; Tremaroli, Valentina; Gastaldelli, Amalia; Mingrone, Geltrude | |
| GLP-1 enhances β-cell response to protein ingestion and bariatric surgery amplifies it | 1-gen-2024 | Rayas, M.; Pezzica, S.; Honka, H.; Carli, F.; Peterson, R.; Defronzo, R.; Gastaldelli, A.; Salehi, M. | |
| GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss | 1-gen-2024 | Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A. | |
| Hepatic glucose metabolism in the steatotic liver | 1-gen-2024 | Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A. | |
| Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study | 1-gen-2024 | Patarrao, R. S.; Meneses, M. J.; Ghadieh, H. E.; Herrera, L.; Duarte, S.; Ribeiro, R. T.; Raposo, J. F.; Schmitt, V.; Singer, B. B.; Gastaldelli, A.; Penha-Goncalves, C.; Najjar, S. M.; Macedo, M. P. | |
| Lipid metabolism in MASLD and MASH: From mechanism to the clinic | 1-gen-2024 | Carli, F.; Della Pepa, G.; Sabatini, S.; Vidal Puig, A.; Gastaldelli, A. | |
| Brain histone beta-hydroxybutyrylation couples metabolism with gene expression | 1-gen-2023 | Cornuti, Sara; Chen, Siwei; Lupori, Leonardo; Finamore, Francesco; Carli, Fabrizia; Samad, Muntaha; Fenizia, Simona; Caldarelli, Matteo; Damiani, Francesca; Raimondi, Francesco; Mazziotti, Raffaele; Magnan, Christophe; Rocchiccioli, Silvia; Gastaldelli, Amalia; Baldi, Pierre; Tognini, Paola | |
| Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy | 1-gen-2023 | Drago, Gaspare; Ruggieri, Silvia; Sprovieri, Mario; Rizzo, Giulia; Colombo, Paolo; Giosuè, Cristina; Quinci, Enza; Traina, Anna; Gastaldelli, Amalia; Cibella, Fabio; Panunzi, Simona | |
| Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk | 1-gen-2023 | Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia | |
| Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective | 1-gen-2023 | Eskridge, W.; Cryer, D. R.; Schattenberg, J. M.; Gastaldelli, A.; Malhi, H.; Allen, A. M.; Noureddin, M.; Sanyal, A. J. |